CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 98(Granted Patents)

Location History:

Aidni-Ken, JP (2001)
Seki, JP (2002)
Aichi-ken, JP (2003)
Taketoyo-cho, JP (2005 - 2006)
Chita-Gun, JP (2005 - 2014)
Aichi, JP (2014 - 2017)
Nagoya, JP (2021)

Company Filing History:

Asahi Kasei Pharma Corporation

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12295947 - Tetrahydroquinoline derivatives as P2X7 receptor antagonists (2025-05-13),

2. 11077100 - Tetrahydroquinoline derivatives as P2X7 receptor antagonists (2021-08-03),

3. 9833447 - 5-HT4 receptor agonist for gastroparesis (2017-12-05),

4. 9187463 - Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid (2015-11-17),

5. 8969383 - Picolinamide derivatives as TTX-S blockers (2015-03-03),

6. 8816090 - Benzisoxazole derivatives (2014-08-26),

7. 8809380 - Picolinamide derivatives as TTX-S blockers (2014-08-19),

8. 8697877 - Oxyindole derivatives with motilin receptor agonistic activity (2014-04-15),

9. 7012080 - [object Object] (2006-03-14),

10. 6951867 - N-substituted piperidinyl-imidazopyridine compounds as 5-HT4 receptor modulators (2005-10-04),

11. 6861425 - Benzimidazole compounds as ORL1-receptor agonists (2005-03-01),

12. 6624162 - Imidazopyridine compounds as 5-HT4 receptor modulators (2003-09-23),

13. 6423725 - 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists (2002-07-23),

14. 6172067 - 2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists (2001-01-09),

Title: Hirohide Noguchi: Innovator in Pharmaceutical Chemistry

Introduction

Hirohide Noguchi is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 14 patents to his name, Noguchi's work has had a substantial impact on medical science.

Latest Patents

Among his latest innovations are the tetrahydroquinoline derivatives, which serve as P2X7 receptor antagonists. These compounds are designed to address various disorders mediated via the P2X7 receptor. The invention encompasses not only the tetrahydroquinoline derivatives themselves but also their pharmaceutically acceptable salts and prodrugs. Additionally, the processes for their preparation and the pharmaceutical compositions containing them are detailed in his patents.

Career Highlights

Hirohide Noguchi has had a distinguished career, working with leading pharmaceutical companies such as Pfizer Corporation and Raqualia Pharma Inc. His expertise in drug development and innovation has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Noguchi has collaborated with notable colleagues, including Yoshimasa Arano and Chikara Uchida. These partnerships have further enhanced his research and development efforts.

Conclusion

Hirohide Noguchi's contributions to pharmaceutical chemistry and his innovative patents reflect his dedication to advancing medical science. His work continues to influence the development of new therapeutic options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.